• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用响应面法和蛋白质结构预测优化抗病毒蓝藻素-N同源基因的表达

Optimizing expression of antiviral cyanovirin-N homology gene using response surface methodology and protein structure prediction.

作者信息

Lotfi H, Hejazi M A, Heshmati M K, Mohammadi S A, Zarghami N

机构信息

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Department of Genomics, Branch for the Northwest and West Region, Agricultural Biotechnology Research Institute of Iran (ABRII), Agriculture research, Education and Extension Organization (AREEO), Tabriz, Iran.

出版信息

Cell Mol Biol (Noisy-le-grand). 2017 Sep 30;63(9):96-105. doi: 10.14715/cmb/2017.63.9.17.

DOI:10.14715/cmb/2017.63.9.17
PMID:28980928
Abstract

Cyanovirin-N (CVN) is well known as an anti-HIV protein. The efficient production of low cost microbicides for preventing the HIV-infection  has lately become a requirement worldwide. The aim of the present study was to optimize the expression of antiviral Cyanovirin-N homology gene found in the indigenous strain of Nostoc ellipsospourum LZN using Response Surface Methodology (RSM) and Protein Structure Analysis. Optimization of three induction factors (IPTG concentration (0.1, 0.55 and 1mM), temperature for bacterial growth (20, 28.5 and 37°C) and induction time (4, 10 and 16h) was done using RSM and Box-Behnken Design. Total RNA extraction was performed and mRNA levels were quantified in each experimental design by one-step SYBR qPCR. Protein structure was predicted using I-TASSER server. The full-length sequence of LZN-CVN gene is 306 bp in length, due mostly to five mutations. RSM analysis showed that the optimum condition to obtain maximum fold change was a concentration of 0.6mM IPTG, temperature set to 29°C and a 12h long induction time. The extracted protein from periplasmic fraction (8 kDa) was verified via SDS-PAGE. The high percentage of LZN-CVN similarity was demonstrated with PDB (Protein Data Bank) accession code of 2rp3A (CVN domain B mutant) and the ligand binding sites were related to N42, V43, D44, G45, S52, N53 and E56 residues. Different expression systems could assist in the development of anti-HIV proteins in a large scale. The LZN-CVN protein was successfully expressed in the E.coli system. RSM could be applied to a series of mathematical and statistical methods for modeling and analysis of responses which are influenced by various variables of interest.

摘要

氰病毒素 - N(CVN)是一种著名的抗HIV蛋白。高效生产低成本的用于预防HIV感染的杀菌剂近来已成为全球的一项需求。本研究的目的是利用响应面法(RSM)和蛋白质结构分析优化在椭圆念珠藻LZN本地菌株中发现的抗病毒氰病毒素 - N同源基因的表达。使用RSM和Box - Behnken设计对三个诱导因子(IPTG浓度(0.1、0.55和1mM)、细菌生长温度(20、28.5和37°C)以及诱导时间(4、10和16小时))进行优化。进行总RNA提取,并通过一步SYBR qPCR在每个实验设计中对mRNA水平进行定量。使用I - TASSER服务器预测蛋白质结构。LZN - CVN基因的全长序列为306 bp,主要是由于五个突变。RSM分析表明,获得最大倍数变化的最佳条件是IPTG浓度为0.6mM、温度设定为29°C以及诱导时间为12小时。通过SDS - PAGE验证了从周质部分提取的8 kDa蛋白质。LZN - CVN与蛋白质数据库(PDB)登录号为2rp3A(CVN结构域B突变体)具有较高的相似性,并且配体结合位点与N42、V43、D44、G45、S52、N53和E56残基相关。不同的表达系统有助于大规模开发抗HIV蛋白。LZN - CVN蛋白在大肠杆菌系统中成功表达。RSM可应用于一系列数学和统计方法,用于对受各种感兴趣变量影响的响应进行建模和分析。

相似文献

1
Optimizing expression of antiviral cyanovirin-N homology gene using response surface methodology and protein structure prediction.利用响应面法和蛋白质结构预测优化抗病毒蓝藻素-N同源基因的表达
Cell Mol Biol (Noisy-le-grand). 2017 Sep 30;63(9):96-105. doi: 10.14715/cmb/2017.63.9.17.
2
The anti-HIV cyanovirin-N domain is evolutionarily conserved and occurs as a protein module in eukaryotes.抗HIV的氰苷菌素-N结构域在进化上是保守的,并且作为一种蛋白质模块存在于真核生物中。
Proteins. 2005 Sep 1;60(4):670-8. doi: 10.1002/prot.20543.
3
[Expression, purification and activity determination of cyanovirin-N].[蓝藻素-N的表达、纯化及活性测定]
Sheng Wu Gong Cheng Xue Bao. 2010 Apr;26(4):538-44.
4
Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.氰病毒素 - N对HIV - 1融合的强效抑制仅需一个高亲和力碳水化合物结合位点:低亲和力碳水化合物结合位点敲除突变体的表征
J Mol Biol. 2002 Apr 19;318(1):1-8. doi: 10.1016/S0022-2836(02)00045-1.
5
A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity.氰病毒素-N的单价突变体有助于深入了解与gp120的多重相互作用对抗病毒活性的作用。
Biochemistry. 2007 Aug 14;46(32):9199-207. doi: 10.1021/bi700666m. Epub 2007 Jul 18.
6
A flexible docking scheme efficiently captures the energetics of glycan-cyanovirin binding.一种灵活的对接方案有效地捕捉了聚糖与氰病毒结合的能量学。
Biophys J. 2014 Mar 4;106(5):1142-51. doi: 10.1016/j.bpj.2014.01.040.
7
The antiviral protein cyanovirin-N: the current state of its production and applications.抗病毒蛋白氰病毒-N:其生产和应用的现状。
Appl Microbiol Biotechnol. 2010 Apr;86(3):805-12. doi: 10.1007/s00253-010-2470-1. Epub 2010 Feb 17.
8
Soluble cytoplasmic expression, rapid purification, and characterization of cyanovirin-N as a His-SUMO fusion.可溶性细胞质表达、快速纯化及 His-SUMO 融合型氰病毒 N 的特性分析。
Appl Microbiol Biotechnol. 2010 Jan;85(4):1051-60. doi: 10.1007/s00253-009-2078-5. Epub 2009 Jun 23.
9
Rational and computational design of stabilized variants of cyanovirin-N that retain affinity and specificity for glycan ligands.理性设计和计算稳定化的氰钴胺素-N 变体,保留对糖配体的亲和力和特异性。
Biochemistry. 2011 Dec 13;50(49):10698-712. doi: 10.1021/bi201411c. Epub 2011 Nov 16.
10
Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping.蓝绿菌素-N糖结合位点突变体的溶液和晶体结构:无结构域交换的证据
Structure. 2008 Aug 6;16(8):1183-94. doi: 10.1016/j.str.2008.05.011.

引用本文的文献

1
Evaluation of Immunogenicity, Protective Immunity on Aquaculture Pathogenic and Fermentation of Flagellin FlaC Protein.鞭毛蛋白FlaC蛋白的免疫原性、对水产养殖病原菌的保护性免疫及发酵评估
Iran J Biotechnol. 2019 Sep 1;17(3):e2628. doi: 10.29252/ijb.2628. eCollection 2019 Sep.
2
An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.蓝绿菌素-N重组蛋白表达系统的更新及临床前开发面临的挑战。
Bioimpacts. 2018;8(2):139-151. doi: 10.15171/bi.2018.16. Epub 2017 Nov 16.